ID 1835 -
Fosfolipidy
PL: Fosfolipidy
EN: Phospolipids
Pdf: phospholipids
Oświadczenie (2)
- stan psychiczny i wydajność
1. Charakterystyka żywności / składnika
The food constituent that is the subject of the health claim is phospholipids which are a major component of all cell membranes. Most phospholipids contain a diglyceride, a phosphate group, and a simple organic molecule such as choline.
The proposed source of phospholipids is from animal lecithin water emulsion derived from the brain tissue of domestic pig. Active constituents of the animal lecithin water emulsion derived from the brain tissue of domestic pig emulsion include linoleic acid and alpha-linoleic acid as fatty acids and choline. No further details are given in the references provided on either the production process or the composition of this phospholipid emulsion.
The Panel considers that the food constituent, phospholipids, which is the subject of the health claim, is not sufficiently characterised.
2.2. Pamięć, zdolność uczenia się i utrzymywania uwagi i funkcjonowanie układu nerwowego (ID 1835)
The claimed effect is “mental state and performance”. The Panel assumed that the target population is the general population.
In the context of the proposed wording, the Panel assumes that the claimed effect refers to memory, learning and concentration (attention), and function of the nervous system.
The Panel considers that normal memory, learning capacity and attention, and normal function of the nervous system are beneficial to human health.
3.2. Pamięć, zdolność uczenia się i utrzymywania uwagi i funkcjonowanie układu nerwowego (ID 1835)
The references cited to substantiate the claimed effects included 10 references of which four were on lecithin, one was on choline alfoscerate, one on docosahexaenoic acid, two on omega-3-fatty acids and two on fatty acids in general.
Five references were related to memory, learning and concentration: two reviews on positive effects from fatty acids on brain function; two studies on lecithin treatment of patients with Alzheimers disease and patients with impaired cognitive functions, respectively; and, one study on choline alfoscerate and cognitive impairment of patients with mild to moderate dementia of the Alzheimer type. The other five references were related to the nervous system: three were reviews on effects of fatty acids in neurological development, on neuroprotective effects in the retina and on membrane
structure and function of neuronal tissues; and two were on lecithin as a possible treatment of tardive dyskinesia.
The Panel considers that the evidence provided does not establish that results obtained with the patient populations studied can be extrapolated to the general population, and that the other references provided did not address the relationship between the consumption of phospholipids (animal lecithin water emulsion derived from the brain tissue of domestic pig) and memory, learning, attention and function of the nervous system.
The Panel concludes that a cause and effect relationship has not been established between the consumption of phospholipids and normal memory, learning capacity and attention, and normal function of the nervous system.
Warunki i możliwe ograniczenia stosowania oświadczenia
Food supplement with phospholipid content of 2500mg/100 g = dose.
This is an animal lecithin water emulsion derived from the brain tissue of domestic pig.
Active ingredients include linoleic acid (= fatty acid), alpha-linoleic acid (= fatty acid) and choline (= phosphatidylcholine).